Year |
Citation |
Score |
2018 |
Mabrey FL, Chien SS, Martins TS, Annis J, Sekizaki TS, Dai J, Beckman RA, Loeb LA, Carson A, Patay B, Blau CA, Oehler VG, Celik SS, Lee S, Monnat RJ, et al. High Throughput Drug Screening of Leukemia Stem Cells Reveals Resistance to Standard Therapies and Sensitivity to Other Agents in Acute Myeloid Leukemia Blood. 132: 180-180. DOI: 10.1182/Blood-2018-180 |
0.32 |
|
2015 |
Sperber H, Mathieu J, Wang Y, Ferreccio A, Hesson J, Xu Z, Fischer KA, Devi A, Detraux D, Gu H, Battle SL, Showalter M, Valensisi C, Bielas JH, Ericson NG, ... ... Blau CA, et al. The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition. Nature Cell Biology. PMID 26571212 DOI: 10.1038/Ncb3264 |
0.659 |
|
2015 |
Ma W, Ay F, Lee C, Gulsoy G, Deng X, Cook S, Hesson J, Cavanaugh C, Ware CB, Krumm A, Shendure J, Blau CA, Disteche CM, Noble WS, Duan Z. Fine-scale chromatin interaction maps reveal the cis-regulatory landscape of human lincRNA genes. Nature Methods. 12: 71-8. PMID 25437436 DOI: 10.1038/Nmeth.3205 |
0.319 |
|
2015 |
Belay E, Miller CP, Kortum AN, Torok-Storb B, Blau CA, Emery DW. A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor. Blood. 125: 1025-33. PMID 25343958 DOI: 10.1182/blood-2014-02-555318 |
0.389 |
|
2014 |
Ware CB, Nelson AM, Mecham B, Hesson J, Zhou W, Jonlin EC, Jimenez-Caliani AJ, Deng X, Cavanaugh C, Cook S, Tesar PJ, Okada J, Margaretha L, Sperber H, Choi M, ... Blau CA, et al. Derivation of naive human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 111: 4484-9. PMID 24623855 DOI: 10.1073/Pnas.1319738111 |
0.654 |
|
2012 |
Zhou W, Choi M, Margineantu D, Margaretha L, Hesson J, Cavanaugh C, Blau CA, Horwitz MS, Hockenbery D, Ware C, Ruohola-Baker H. HIF1α induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition. The Embo Journal. 31: 2103-16. PMID 22446391 DOI: 10.1038/Emboj.2012.71 |
0.645 |
|
2011 |
Mathieu J, Zhang Z, Zhou W, Wang AJ, Heddleston JM, Pinna CM, Hubaud A, Stadler B, Choi M, Bar M, Tewari M, Liu A, Vessella R, Rostomily R, Born D, ... ... Blau CA, et al. HIF induces human embryonic stem cell markers in cancer cells. Cancer Research. 71: 4640-52. PMID 21712410 DOI: 10.1158/0008-5472.Can-10-3320 |
0.404 |
|
2010 |
Stadler B, Ivanovska I, Mehta K, Song S, Nelson A, Tan Y, Mathieu J, Darby C, Blau CA, Ware C, Peters G, Miller DG, Shen L, Cleary MA, Ruohola-Baker H. Characterization of microRNAs involved in embryonic stem cell states. Stem Cells and Development. 19: 935-50. PMID 20128659 DOI: 10.1089/Scd.2009.0426 |
0.339 |
|
2009 |
Ware CB, Wang L, Mecham BH, Shen L, Nelson AM, Bar M, Lamba DA, Dauphin DS, Buckingham B, Askari B, Lim R, Tewari M, Gartler SM, Issa JP, Pavlidis P, ... ... Blau CA, et al. Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell. 4: 359-69. PMID 19341625 DOI: 10.1016/J.Stem.2009.03.001 |
0.512 |
|
2008 |
Lin EH, Jiang Y, Deng Y, Lapsiwala R, Lin T, Blau CA. Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisited. Gastrointestinal Cancer Research : Gcr. 2: 169-74. PMID 19259284 |
0.393 |
|
2006 |
Blau CA, Peterson KR. Establishment of cell lines that exhibit correct ontogenic stage-specific gene expression profiles from tissues of yeast artificial chromosome transgenic mice using chemically induced growth signals Methods in Molecular Biology (Clifton, N.J.). 349: 163-173. PMID 17071982 |
0.349 |
|
2006 |
Nagasawa Y, Wood BL, Wang L, Lintmaer I, Guo W, Papayannopoulou T, Harkey MA, Nourigat C, Blau CA. Anatomical compartments modify the response of human hematopoietic cells to a mitogenic signal Stem Cells. 24: 908-917. PMID 16373691 DOI: 10.1634/stemcells.2005-0484 |
0.436 |
|
2005 |
Blau CA, Barbas CF, Bomhoff AL, Neades R, Yan J, Navas PA, Peterson KR. γ-globin gene expression in chemical inducer of dimerization (CID)-dependent multipotential cells established from human β-globin locus yeast artificial chromosome (β-YAC) transgenic mice Journal of Biological Chemistry. 280: 36642-36647. PMID 16131492 DOI: 10.1074/jbc.M504402200 |
0.318 |
|
2005 |
Richard RE, Siritanaratkul N, Jonlin E, Skarpidi E, Heimfeld S, Blau CA. Collection of blood stem cells from patients with sickle cell anemia. Blood Cells, Molecules & Diseases. 35: 384-8. PMID 16125985 DOI: 10.1016/j.bcmd.2005.06.014 |
0.41 |
|
2005 |
Emery DW, Tubb J, Nishino Y, Nishino T, Otto KG, Stamatoyannopoulos G, Blau CA. Selection with a regulated cell growth switch increases the likelihood of expression for a linked gamma-globin gene. Blood Cells, Molecules & Diseases. 34: 235-47. PMID 15885608 DOI: 10.1016/j.bcmd.2005.01.004 |
0.402 |
|
2004 |
Richard RE, De Claro RA, Yan J, Chien S, Von Recum H, Morris J, Kiem HP, Dalgarno DC, Heimfeld S, Clackson T, Andrews R, Blau CA. Differences in F36VMpl-based in vivo selection among large animal models. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 730-40. PMID 15451457 DOI: 10.1016/j.ymthe.2004.07.005 |
0.318 |
|
2004 |
Zhao S, Weinreich MA, Ihara K, Richard RE, Blau CA. In vivo selection of genetically modified erythroid cells using a jak2-based cell growth switch. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 456-68. PMID 15336646 DOI: 10.1016/J.Ymthe.2004.05.014 |
0.302 |
|
2004 |
Zhao SM, Gu XC, Chang NB, Clackson T, Blau CA. [Long term regulated expansion and committed differentiation of JAK2 gene transfected hematopoietic stem/progenitor cells in vitro]. Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi. 25: 65-9. PMID 14990041 |
0.458 |
|
2004 |
Berger C, Blau CA, Huang ML, Iuliucci JD, Dalgarno DC, Gaschet J, Heimfeld S, Clackson T, Riddell SR. Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model. Blood. 103: 1261-9. PMID 14563634 DOI: 10.1182/blood-2003-08-2908 |
0.326 |
|
2003 |
Richard RE, Blau CA. Small-molecule-directed mpl signaling can complement growth factors to selectively expand genetically modified cord blood cells. Stem Cells (Dayton, Ohio). 21: 71-8. PMID 12529553 DOI: 10.1634/stemcells.21-1-71 |
0.408 |
|
2000 |
Richard RE, Wood B, Zeng H, Jin L, Papayannopoulou T, Blau CA. Expansion of genetically modified primary human hemopoietic cells using chemical inducers of dimerization. Blood. 95: 430-6. PMID 10627446 |
0.42 |
|
1998 |
Blau CA. Current status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesis. BaillièRe's Clinical Haematology. 11: 257-75. PMID 10872481 |
0.378 |
|
1997 |
Blau CA, Neff T, Papayannopoulou T. Cytokine prestimulation as a gene therapy strategy: implications for using the MDR1 gene as a dominant selectable marker. Blood. 89: 146-54. PMID 8978287 |
0.382 |
|
1996 |
Blau CA, Neff T, Papayannopoulou T. The hematological effects of folate analogs: implications for using the dihydrofolate reductase gene for in vivo selection. Human Gene Therapy. 7: 2069-78. PMID 8934221 DOI: 10.1089/hum.1996.7.17-2069 |
0.392 |
|
1994 |
Stamatoyannopoulos G, Blau CA, Nakamoto B, Josephson B, Li Q, Liakopoulou E, Pace B, Papayannopoulou T, Brusilow SW, Dover G. Fetal hemoglobin induction by acetate, a product of butyrate catabolism. Blood. 84: 3198-204. PMID 7524768 DOI: 10.1182/Blood.V84.9.3198.3198 |
0.322 |
|
1993 |
Papayannopoulou T, Brice M, Blau CA. Kit ligand in synergy with interleukin-3 amplifies the erythropoietin-independent, globin-synthesizing progeny of normal human burst-forming units-erythroid in suspension cultures: physiologic implications. Blood. 81: 299-310. PMID 7678508 DOI: 10.1182/Blood.V81.2.299.Bloodjournal812299 |
0.52 |
|
1991 |
Abkowitz JL, Sabo KM, Nakamoto B, Blau CA, Martin FH, Zsebo KM, Papayannopoulou T. Diamond-blackfan anemia: in vitro response of erythroid progenitors to the ligand for c-kit. Blood. 78: 2198-202. PMID 1718487 DOI: 10.1182/Blood.V78.9.2198.2198 |
0.378 |
|
Show low-probability matches. |